Malaysia Withdraws Appeal Against Liquid Nicotine Ruling as Vape Regulation Framework Enters New Phase

Aug.21
Malaysia Withdraws Appeal Against Liquid Nicotine Ruling as Vape Regulation Framework Enters New Phase
Malaysia’s government has withdrawn its appeal against a High Court ruling concerning the regulatory status of liquid nicotine used in vape and e-cigarette products, according to reports by New Straits Times, Free Malaysia Today and CodeBlue on August 18, 2026. The Kuala Lumpur High Court ruled on May 15 that the government’s decision to remove liquid nicotine from the scheduled poisons list under the Poisons Act 1952 was irrational and made without proper consultation with the Poisons Board. The withdrawal ends the government’s appeal process, while the future regulatory framework for nicotine vape products remains under discussion.

Key Points

  • Malaysia’s government withdrew its appeal against a High Court ruling on liquid nicotine regulation on August 18, 2026.
  • The case involved the 2023 decision to remove liquid nicotine used in vape products from the Poisons Act 1952 scheduled poisons list.
  • The High Court ruled that the decision was irrational and made without proper consultation with the Poisons Board.
  • The withdrawal does not represent a new vape ban or a regulatory relaxation policy.
  • The decision may affect the legal framework governing nicotine-containing vape products in Malaysia.

2Firsts

August 21, 2026

Malaysia’s government has withdrawn its appeal against a High Court ruling concerning the regulatory status of liquid nicotine used in vape and e-cigarette products, according to reports by New Straits Times on August 18, 2026.

The Attorney-General’s Chambers (AGC), representing the health minister and the government, filed a notice of discontinuance at the Court of Appeal, ending the appeal process against the High Court decision.

The notice, dated August 18, stated that the health minister and the Malaysian government wished to withdraw and discontinue the entire appeal against the respondents without orders as to costs.

The case concerns whether liquid nicotine used in vape and e-cigarette products should remain regulated under the Poisons Act 1952.

Court Previously Overturned Liquid Nicotine Exemption Decision

The government’s withdrawal follows a Kuala Lumpur High Court ruling issued on May 15, 2026.

In 2023, Malaysia removed liquid nicotine and nicotine gels used in vape and e-cigarette products from the scheduled poisons list through amendments to the Poisons List.

The move was linked to the government’s plan to establish taxation for nicotine-containing vape liquids.

Three non-governmental organisations — the Malaysian Council for Tobacco Control, Malaysian Green Lung Association and Voice of the Children — subsequently filed a judicial review application challenging the decision.

On May 15, Justice Aliza Sulaiman ruled that the government’s decision to remove liquid nicotine from the poisons list was “irrational” and made without proper or adequate consultation with the Poisons Board.

The court also found that the decision was ultra vires Section 6 of the Poisons Act 1952.

Appeal Withdrawal Leaves Regulatory Questions

Following the High Court ruling, Health Minister Dzulkefly Ahmad and the Malaysian government filed an appeal challenging the decision.

According to CodeBlue, a senior federal counsel from the Attorney-General’s Chambers submitted a notice of discontinuance at the Court of Appeal on August 18, ending the government’s appeal.

The withdrawal means the government will no longer continue its challenge against the High Court ruling through the appeal process.

However, the move does not itself represent a new vape regulation or a formal ban.

CodeBlue reported that it remains unclear whether the withdrawal means retail sales of nicotine vape products would effectively become illegal, as the legal status of liquid nicotine remains linked to the interpretation of the Poisons Act.

Liquid Nicotine Regulation at the Centre of Legal Dispute

The legal dispute focuses on the classification of liquid nicotine under Malaysia’s regulatory framework.

The case concerns:

● liquid nicotine used in vape products;

● whether nicotine-containing vape products should remain subject to the Poisons Act 1952.

The ruling does not directly create a new regulation covering all vape devices or all electronic cigarette products, but instead addresses the legal basis for regulating nicotine-containing vape products.

For the vaping industry, attention is now focused on how Malaysia addresses:

● regulatory authority over liquid nicotine products;

● import and sales compliance requirements;

● existing tax and regulatory arrangements.

Malaysia Enters New Regulatory Review Phase

Malaysia has continued adjusting its regulatory framework for vape and nicotine products in recent years.

The Control of Smoking Products for Public Health Act 2024, which came into force in 2024, established a broader framework for regulating smoking products including vape products.

The liquid nicotine court ruling and the government’s decision to withdraw its appeal have renewed attention on how nicotine products are regulated across different legal frameworks.

Further government action, including potential legislative or regulatory changes, remains to be seen.

Follow 2Firsts for the latest updates on global tobacco and nicotine regulation, market developments and policy trends.

Cover Image source: New Straits Times


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor Ron DeSantis announced an expansion of Temporary Assistance for Needy Families (TANF) restrictions that would prohibit Electronic Benefit Transfer (EBT) funds from being used to purchase tobacco and vaping products. The state will amend its TANF State Plan and submit the changes for federal approval. Florida officials said the restrictions would not affect eligibility for temporary cash assistance or the amount of benefits received, but would change how funds can be spent.
Aug.25
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21